Evidence Level
Vitamin B6 has strong evidence for morning sickness treatment, with the ACOG recommending pyridoxine (10-25 mg, 3 times daily) as first-line therapy. The FDA-approved combination of doxylamine/pyridoxine (Diclegis) is supported by multiple RCTs. Wyatt et al. (1999) published a BMJ systematic review of 9 RCTs demonstrating B6 at 50-100 mg/day significantly improved PMS symptoms. For neurology, Hvas et al. (2004) showed that B6 supplementation improved mood in subjects with marginal B6 deficiency. The neuropathy risk at chronic high doses (>200 mg/day) is well-documented and led to the 100 mg/day UL.